Astrocyte: A Foe or a Friend in Intellectual Disability-Related Diseases

被引:2
|
作者
Wang, Busong [1 ]
Zou, Lu [1 ]
Li, Min [1 ]
Zhou, Liang [1 ]
机构
[1] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
astrocyte; intellectual disability; drug therapy; neurodevelopment; central nervous system; TUBEROUS SCLEROSIS; MOUSE MODEL; REACTIVE ASTROCYTES; GLUTAMATE; PIRACETAM; EXPOSURE; HOMEOSTASIS; ACTIVATION; EXPRESSION; GLIA;
D O I
10.3389/fnsyn.2022.877928
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intellectual disabilities are a type of neurodevelopmental disease caused by neurological dysfunction. Their incidence is largely associated with neural development. Astrocytes are the most widely distributed cells in the mammalian brain. Previous studies have reported that astrocytes only supported and separated the neurons in the brain. However, recent studies have found that they also play an important role in neural development. Understanding the astrocyte mechanism in intellectual development disorder-related diseases will help provide new therapeutic targets for the treatment of intellectual disability-related diseases. This mini-review introduced the association between astrocyte and intellectual disabilities. Furthermore, recent advances in genetic and environmental factors causing intellectual disability and different pharmaceutical effects of intellectual disability-related drugs on astrocytes have been summarised. Finally, we discussed future perspectives of astrocyte-based therapy for intellectual disability.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Disability-related risks
    Neumann, PG
    Byrne, MD
    [J]. COMMUNICATIONS OF THE ACM, 2005, 48 (08) : 144 - 144
  • [2] Butyrate Properties in Immune-Related Diseases: Friend or Foe?
    Anshory, Muhammad
    Effendi, Raden Mohamad Rendy Ariezal
    Kalim, Handono
    Dwiyana, Reiva Farah
    Suwarsa, Oki
    Nijsten, Tamar E. C.
    Nouwen, Jan L.
    Thio, Hok Bing
    [J]. FERMENTATION-BASEL, 2023, 9 (03):
  • [3] Contribution of Intellectual Disability-Related Genes to ADHD Risk and to Locomotor Activity in Drosophila
    Klein, Marieke
    Singgih, Euginia L.
    van Rens, Anne
    Demontis, Ditte
    Borglum, Anders D.
    Mota, Nina Roth
    Castells-Nobau, Anna
    Kiemeney, Lambertus A.
    Brunner, Han G.
    Arias-Vasquez, Alejandro
    Schenck, Annette
    van der Voet, Monique
    Franke, Barbara
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2020, 177 (06): : 526 - 536
  • [4] Disability-related abuse in people with intellectual and developmental disabilities: Considerations across the lifespan
    Lund, Emily M.
    [J]. PREVENTION SCIENCE AND RESEARCH IN INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2021, 61 : 77 - 97
  • [5] Disability-related resources on the Internet
    Schmetzke, A
    [J]. INTERVENTION IN SCHOOL AND CLINIC, 1996, 32 (02) : 69 - 81
  • [6] Oestrogens in rheumatic diseases: friend or foe?
    Cutolo, M.
    Capellino, S.
    Straub, R. H.
    [J]. RHEUMATOLOGY, 2008, 47 : 2 - 5
  • [7] THE SUN AND RHEUMATIC DISEASES: FRIEND OR FOE?
    Cutolo, Maurizio
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S31 - S31
  • [8] An Intellectual Disability-Related Missense Mutation in Rac1 Prevents LTP Induction
    Tian, Chen
    Kay, Yuni
    Sadybekov, Anastasiia
    Rao, Sadhna
    Katritch, Vsevolod
    Herring, Bruce E.
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [9] Amyloid in neurodegenerative diseases: Friend or foe?
    Wolfe, Katie J.
    Cyr, Douglas M.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2011, 22 (05) : 476 - 481
  • [10] Platelets in Rheumatic Diseases: Friend or Foe?
    Gasparyan, Armen Yuri
    Ayvazyan, Lilit
    Pretorius, Etheresia
    Kitas, George D.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (04) : 552 - 566